PolyPeptide Group AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 320.37 million compared to EUR 280.98 million a year ago. Revenue was EUR 324.85 million compared to EUR 283.46 million a year ago.

Net loss was EUR 51.44 million compared to net income of EUR 7.77 million a year ago. Basic loss per share from continuing operations was EUR 1.56 compared to basic earnings per share from continuing operations of EUR 0.24 a year ago. Diluted loss per share from continuing operations was EUR 1.56 compared to diluted earnings per share from continuing operations of EUR 0.24 a year ago.